Search results for "Antimicrobials"

showing 10 items of 37 documents

Rational Design of a Carrier Protein for the Production of Recombinant Toxic Peptides in Escherichia coli

2016

Commercial uses of bioactive peptides require low cost, effective methods for their production. We developed a new carrier protein for high yield production of recombinant peptides in Escherichia coli very well suited for the production of toxic peptides like antimicrobial peptides. GKY20, a short antimicrobial peptide derived from the C-terminus of human thrombin, was fused to the C-terminus of Onconase, a small ribonuclease (104 amino acids), which efficiently drove the peptide into inclusion bodies with very high expression levels (about 200-250 mg/L). After purification of the fusion protein by immobilized metal ion affinity chromatography, peptide was obtained by chemical cleavage in d…

Genetics and Molecular Biology (all)0301 basic medicineProtein ExpressionCarboxylic Acidslcsh:MedicinePeptideMedicine (all); Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)medicine.disease_causeBiochemistrylaw.inventionlawMedicine and Health SciencesAmino Acidslcsh:ScienceAcetic Acidchemistry.chemical_classificationAntimicrobial Cationic PeptideMultidisciplinaryAntimicrobialsOrganic CompoundsHydrolysisMedicine (all)Chemical ReactionsDrugsRecombinant ProteinRecombinant ProteinsAmino acidChemistryBiochemistryPhysical SciencesRecombinant DNAHumanResearch Article030106 microbiologyAntimicrobial peptidesResearch and Analysis MethodsMicrobiologyRibonuclease03 medical and health sciencesResidue (chemistry)RibonucleasesAffinity chromatographyMicrobial ControlGene Expression and Vector TechniquesEscherichia colimedicineSulfur Containing Amino AcidsHumansCysteineMolecular Biology TechniquesMolecular BiologyEscherichia coliPharmacologyMolecular Biology Assays and Analysis TechniquesBiochemistry Genetics and Molecular Biology (all)lcsh:ROrganic ChemistryFormic AcidChemical CompoundsBiology and Life SciencesProteins030104 developmental biologyAgricultural and Biological Sciences (all)chemistrylcsh:QCarrier ProteinPeptidesCarrier ProteinsAcidsAntimicrobial Cationic PeptidesCysteinePLOS ONE
researchProduct

In silico identification and experimental validation of hits active against KPC-2 β-lactamase

2018

Bacterial resistance has become a worldwide concern, particularly after the emergence of resistant strains overproducing carbapenemases. Among these, the KPC-2 carbapenemase represents a significant clinical challenge, being characterized by a broad substrate spectrum that includes aminothiazoleoxime and cephalosporins such as cefotaxime. Moreover, strains harboring KPC-type β-lactamases are often reported as resistant to available β-lactamase inhibitors (clavulanic acid, tazobactam and sulbactam). Therefore, the identification of novel non β-lactam KPC-2 inhibitors is strongly necessary to maintain treatment options. This study explored novel, non-covalent inhibitors active against KPC-2, …

Genetics and Molecular Biology (all)Proteomics0301 basic medicineCefotaximeKlebsiella pneumoniaePathology and Laboratory MedicinePhysical ChemistryBiochemistryKlebsiella PneumoniaeDatabase and Informatics MethodsBiochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)AntibioticsKlebsiellaCatalytic DomainMedicine and Health Sciencespolycyclic compoundsDrug InteractionsCrystallographyMultidisciplinarybiologyAntimicrobialsOrganic CompoundsProteomic DatabasesChemistryPhysicsQRDrugsSulbactamCondensed Matter PhysicsBacterial PathogensChemistryBiochemistryMedical MicrobiologyPhysical SciencesCrystal StructureMedicinePathogensbeta-Lactamase InhibitorsResearch Articlemedicine.drugScienceIn silico030106 microbiologySulfonamideResearch and Analysis MethodsMicrobiologyMeropenemTazobactambeta-Lactamases03 medical and health sciencesBacterial ProteinsMicrobial ControlClavulanic acidmedicineSolid State PhysicsMicrobial PathogensPharmacologyLigand efficiencyChemical BondingBacteriaOrganic ChemistryChemical CompoundsOrganismsBiology and Life SciencesHydrogen Bondingbiochemical phenomena metabolism and nutritionbiology.organism_classificationbacterial infections and mycosesAmidesBiological Databases030104 developmental biologyAgricultural and Biological Sciences (all)
researchProduct

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

2017

Background Intracellular HCV-RNA reduction is a proposed mechanism of action of direct-acting antivirals (DAAs), alternative to hepatocytes elimination by pegylated-interferon plus ribavirin (PR). We modeled ALT and HCV-RNA kinetics in cirrhotic patients treated with currently-used all-DAA combinations to evaluate their mode of action and cytotoxicity compared with telaprevir (TVR)+PR. Study design Mathematical modeling of ALT and HCV-RNA kinetics was performed in 111 HCV-1 cirrhotic patients, 81 treated with all-DAA regimens and 30 with TVR+PR. Kinetic-models and Cox-analysis were used to assess determinants of ALT-decay and normalization. Results HCV-RNA kinetics was biphasic, reflecting …

Genetics and Molecular Biology (all)SimeprevirMaleHepacivirusHepacivirusPharmacologyBiochemistryStiffness0302 clinical medicineAnimal CellsMedicineAmino Acidslcsh:ScienceAlanineOrganic CompoundsLiver Diseases3. Good healthCirrhosisPhysical SciencesAdministrationInterferon030211 gastroenterology & hepatologyDrug Therapy CombinationCellular TypesOligopeptidesHumanOralMaterials ScienceGastroenterology and HepatologyMicrobiologyAntiviral Agents03 medical and health sciencesDrug TherapyHumansAgedKineticPharmacologyHepaciviruBiochemistry Genetics and Molecular Biology (all)Mathematical Modelinglcsh:RChemical CompoundsBiology and Life SciencesProteinsmedicine.diseasedigestive system diseasesAdministration Oral; Aged; Alanine Transaminase; Antiviral Agents; Drug Therapy Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferons; Kinetics; Male; Middle Aged; Oligopeptides; RNA Viral; Ribavirin; Simeprevir; Sofosbuvir; Treatment Outcome; Viral Nonstructural Proteins; Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)030104 developmental biologyAgricultural and Biological Sciences (all)chemistryAliphatic Amino Acidslcsh:Q0301 basic medicineSofosbuvirlcsh:MedicineAdministration OralMedicine (all); Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)Viral Nonstructural ProteinsTelaprevirchemistry.chemical_compoundSimeprevirMedicine and Health SciencesViralMultidisciplinarybiologyAntimicrobialsMedicine (all)Simulation and ModelingDrugsAlanine TransaminaseHepatitis CMiddle AgedAntiviralsHepatitis CChemistryTreatment OutcomeLiverCombinationOligopeptideRNA ViralFemaleAnatomymedicine.drugResearch ArticleSettore MED/17 - Malattie InfettiveGeneral Science & TechnologyMaterial PropertiesResearch and Analysis MethodsMicrobial ControlVirologyRibavirinMechanical PropertiesNS5AAntiviral Agentbusiness.industryRibavirinHCV DAA ALTViral Nonstructural ProteinOrganic ChemistryCell Biologybiology.organism_classificationKineticsAlanine transaminaseAdministration Oral; Aged; Alanine Transaminase; Antiviral Agents; Drug Therapy Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferons; Kinetics; Male; Middle Aged; Oligopeptides; RNA Viral; Ribavirin; Simeprevir; Sofosbuvir; Treatment Outcome; Viral Nonstructural Proteinsbiology.proteinHepatocytesRNAInterferonsSofosbuvirbusiness
researchProduct

Inbreeding does not alter the response to an experimental heat wave in a freshwater snail

2019

Global climate change affects natural populations of many species by increasing the average temperature and the frequency of extreme weather events (e.g. summer heat waves). The ability of organisms to cope with these environmental changes can, however, depend on their genetic properties. For instance, genetic load owing to inbreeding could alter organisms’ responses to climate change-mediated environmental changes but such effects are often overlooked. We investigated the effects of an experimental heat wave (25°C versus 15°C) on life history (reproduction, size) and constitutive immune defence traits (phenoloxidase-like and antibacterial activity of haemolymph) in relation to inbreeding b…

Hot TemperatureHeredityPhysiologyOvipositionSnailsMarine and Aquatic SciencesMathematical and Statistical TechniquesReproductive PhysiologyMedicine and Health SciencesBody SizeInbreedingImmune ResponseLymnaeaAntimicrobialsReproductionStatisticsQREukaryotaDrugsimmuunivastePhysical SciencesMedicinelämpötilaClutchesympäristönmuutoksetResearch ArticleClimate ChangeScienceImmunologyResearch and Analysis MethodsMicrobiologyMicrobial ControlGeneticsAnimalsLymnaea stagnalisStatistical MethodsPondsPharmacologyEvolutionary BiologyAnalysis of VariancePopulation BiologyfungivesikotilotImmunityOrganismsBiology and Life SciencesMolluscsBodies of WaterilmastonmuutoksetlisääntyminenInvertebratespiippolimakotiloGastropodsEarth SciencesGenetic PolymorphismsukusiitosAntibacterialsPopulation GeneticsMathematics
researchProduct

Green tea extract assisted low-temperature pasteurization to inactivate enteric viruses in juices.

2020

The current popularity of minimally processed foods is an opportunity for natural antimicrobial agents to be combined with mild heat treatments to act synergistically in reducing viral foodborne pathogens. Viral inactivation by heat-treatments (at 25, 40, 50 and 63 °C for 30 min) combined with aged green tea extract (aged-GTE) was initially evaluated in phosphate buffered saline (PBS) against murine norovirus (MNV-1) and hepatitis A virus (HAV) by cell culture, and against human norovirus by in situ capture RT-qPCR. The combination of aged-GTE and heat treatment at 50 °C for 30 min exerted strong antiviral activity, reducing by more than 5 log MNV-1 infectivity in PBS. Heating at 40 °C for …

Hot TemperatureNatural antimicrobialsSwineved/biology.organism_classification_rank.speciesMicrobiologiaHurdle technologyPasteurizationGreen tea extractmedicine.disease_causeAliments MicrobiologiaMicrobiologyAntiviral Agentslaw.inventionFood safetyCell LineFoodborne Diseases03 medical and health sciencesMiceSpecies SpecificitylawmedicineAnimalsHumansFood science030304 developmental biologyInfectivity0303 health sciencesTea030306 microbiologyChemistryved/biologyPlant ExtractsNorovirusGeneral MedicineAntimicrobialFruit and Vegetable JuicesCell cultureNorovirusHurdle technologyPasteurizationVirus InactivationHepatitis A virusFood ScienceMurine norovirusInternational journal of food microbiology
researchProduct

Prevalence survey of healthcare-associated infections and antimicrobial use at the university hospital "paolo giaccone", palermo, italy

2013

Introduction. Healthcare-associated infections (HAIs) and antimicrobial resistance are well known major public health threats. The first goal of our study was to describe the prevalence of HAI, while the second goal was to describe the antibiotic consumption at our University Hospital, ?P. Giaccone? in Palermo, Italy. Methods. A standardized methodology for a combined Point Prevalence Survey (PPS) on healthcare-associated infections (HAIs) and antimicrobial use in European acute care hospital developed by the European Centre for Disease Prevention and Control (ECDC) was piloted across Europe. The teaching Hospital ?P. Giaccone? in Palermo, Italy, participated in the study Results. Out of 32…

MaleAntimicrobials drug resistanceCross Infectionvirus diseasesBacteremiaHealthcare-associated infectionsAntibiotic ProphylaxisMiddle AgedSettore MED/42 - Igiene Generale E ApplicataDrug UtilizationAnti-Bacterial AgentsHospitals UniversityIntensive Care UnitsItalyPoint Prevalence SurveyDrug Resistance BacterialPrevalenceHumansOriginal ArticleFemaleHealthcare associated infection Antibiotic Prophylaxis Prevalence Hospital University
researchProduct

Acute Gastroenteritis and Campylobacteriosis in Swiss primary care: the viewpoint of general practitioners

2016

Acute gastroenteritis (AG) is frequently caused by infectious intestinal diseases (IID) including food- and waterborne pathogens of public health importance. Among these pathogens, Campylobacter spp. plays a major role. Many European countries monitor selected IIDs within disease surveillance systems. In Switzerland, the information on IIDs is restricted to limited surveillance data, while no data is available for AG. We conducted a qualitative study among Swiss general practitioners (GPs) to investigate the case management of AG and campylobacteriosis patients, the associated disease burden and the determinants leading to registration in the National Notification System for Infectious Dise…

MaleBacterial Diseases0301 basic medicinelcsh:MedicineNotification systemPathology and Laboratory MedicineFeces0302 clinical medicineCampylobacteriosisAntibioticsMedical adviceCampylobacter InfectionsMedicine and Health SciencesPublic and Occupational Health030212 general & internal medicinelcsh:ScienceDisease surveillanceMultidisciplinaryAntimicrobialsDrugsGastroenteritisBacterial PathogensInfectious DiseasesMedical MicrobiologyPathogensSwitzerlandResearch ArticleAdultDiarrheamedicine.medical_specialty030106 microbiologyMEDLINECampylobacteriosisGastroenterology and HepatologyResearch and Analysis MethodsMicrobiology03 medical and health sciencesSigns and SymptomsGeneral PractitionersDiagnostic MedicineMicrobial ControlmedicineHumansMicrobial PathogensDisease burdenPharmacologyPrimary Health CareBacteriabusiness.industryPublic healthlcsh:ROrganismsBiology and Life SciencesCampylobactermedicine.diseaseTriageSurgeryIntestinal DiseasesSpecimen Preparation and TreatmentAntibiotic ResistanceFamily medicinelcsh:QAntimicrobial Resistancebusiness
researchProduct

Efficacy and safety of decompressive craniectomy with non-suture duraplasty in patients with traumatic brain injury.

2020

AbstractBackgroundDecompressive craniectomy is an important surgical treatment for patients with severe traumatic brain injury (TBI). Several reports have been published on the efficacy of non-watertight sutures in duraplasty performed in decompressive craniectomy. This study aims to evaluate the effectiveness of dura closure without sutures (non-suture duraplasty) in decompressive craniectomy for TBI.MethodsOne hundred and six patients were enrolled at a single trauma center between January 2017 and December 2018. We retrospectively collected the data and classified the patients into non-suture and suture duraplasty craniectomy groups. We compared the characteristics of patients and their …

MaleCritical Care and Emergency MedicineTraumatic Brain InjuryPhysiologymedicine.medical_treatmentBlood Loss SurgicalGlasgow Outcome ScaleNervous SystemVascular MedicineDiagnostic RadiologyNervous System Procedures0302 clinical medicineSuture (anatomy)AntibioticsBrain Injuries TraumaticMedicine and Health SciencesSurgical treatmentTomographyTrauma MedicineCerebrospinal FluidMultidisciplinaryAntimicrobialsRadiology and ImagingGlasgow Outcome ScaleTrauma centerQRDrugsMiddle AgedSevere Blood LossCranioplastySutureless Surgical ProceduresBody FluidsTreatment OutcomeMedicineFemaleDecompressive craniectomyAnatomyTraumatic InjuryResearch ArticleAdultDecompressive Craniectomymedicine.medical_specialtyImaging TechniquesTraumatic brain injuryScienceOperative TimeTrauma SurgerySurgical and Invasive Medical ProceduresNeuroimagingHemorrhageResearch and Analysis MethodsMicrobiologyCranioplasty03 medical and health sciencesSigns and SymptomsBlood lossDiagnostic MedicineMicrobial ControlmedicineHumansIn patientRetrospective StudiesPharmacologybusiness.industryBiology and Life Sciences030208 emergency & critical care medicinemedicine.diseaseComputed Axial TomographySurgeryDura MaterClinical MedicinebusinessNeurotraumaTrauma surgery030217 neurology & neurosurgeryNeurosciencePLoS ONE
researchProduct

Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors.

2010

Background Current treatment of chronic hepatitis C virus (HCV) infection has limited efficacy −especially among genotype 1 infected patients−, is costly, and involves severe side effects. Thus, predicting non-response is of major interest for both patient wellbeing and health care expense. At present, treatment cannot be individualized on the basis of any baseline predictor of response. We aimed to identify pre-treatment clinical and virological parameters associated with treatment failure, as well as to assess whether therapy outcome could be predicted at baseline. Methodology Forty-three HCV subtype 1b (HCV-1b) chronically infected patients treated with pegylated-interferon alpha plus ri…

MaleHepaciviruslcsh:MedicineHepacivirusmedicine.disease_causePolyethylene Glycolschemistry.chemical_compoundlcsh:ScienceMultidisciplinarybiologyDiscriminant AnalysisHepatitis CMiddle AgedViral LoadPrognosisHepatitis CRecombinant ProteinsTreatment OutcomeGastroenterology and Hepatology/Gastrointestinal InfectionsDrug Therapy CombinationFemaleViral hepatitisViral loadResearch ArticleAdultmedicine.medical_specialtyCombination therapyHepatitis C virusAlpha interferonInterferon alpha-2Antiviral AgentsGastroenterology and Hepatology/HepatologyInternal medicineRibavirinInfectious Diseases/Viral InfectionsmedicineHumansRetrospective StudiesVirology/Antivirals including Modes of Action and ResistanceInfectious Diseases/Antimicrobials and Drug Resistancebusiness.industryRibavirinlcsh:RGenetic VariationInterferon-alphaMicrobiology/Medical MicrobiologyVirology/Mechanisms of Resistance and Susceptibility including Host Geneticsmedicine.diseasebiology.organism_classificationLogistic ModelschemistryImmunologylcsh:QbusinessPLoS ONE
researchProduct

The Use of Intravenous Fosfomycin in Clinical Practice: A 5-Year Retrospective Study in a Tertiary Hospital in Italy

2023

Fosfomycin in intravenous (IV) formulation has re-emerged as a valuable tool in the treatment of multi-drug resistant (MDR) and extensively drug-resistant (XDR) infections because of its broad spectrum of antibacterial action and pharmacokinetic characteristics. This retrospective study aimed to evaluate how fosfomycin was used in patients admitted to the Polyclinic of Palermo between January 2017 and July 2022. Clinical indications, therapeutic associations, clinical outcomes, and any side effects were analyzed. Intravenous fosfomycin was used in 343 patients, 63% male, with a mean age of 68 years (range 15–95). Urinary tract infections (UTIs) and hospital-acquired pneumonia (HAP) were the…

Microbiology (medical)Infectious Diseasesretrospective study.fosfomycin; antimicrobials; gram-negative; retrospective studyantimicrobialPharmacology (medical)General Pharmacology Toxicology and PharmaceuticsfosfomycinBiochemistryMicrobiologygram-negativeAntibiotics; Volume 12; Issue 6; Pages: 971
researchProduct